… -dose inhaled corticosteroids are unknown. We assessed whether the use and dose of inhaled
corticosteroids increase the risk … studies of the risks of glaucoma, cataracts, fractures, and …

… risk of cataract development associated with cumulative ICS exposure (HR 1.43, 95% CI
1.11–1.84), another study [54] reporting on patients undergoing cataract … ICS use and cataract …

Purpose Guidelines and systematic reviews frequently warn of inhaled corticosteroid (ICS)-induced
glaucoma. However, most of the published studies deny it. Methods We performed a …

… inhaled corticosteroids? and (3) How can the clinician reduce the risk of systemic side effects
from inhaled corticosteroids… of inhaled corticosteroid side effects, including cataracts 5 and …

… of inhaled corticosteroids (ICS) on the risk of glaucoma remains uncertain. We sought to
determine the risk … The reported ocular side effects of ICS use consist of cataracts and glaucoma. …

Despite the fact that the recommendations of the main clinical guidelines have restricted the
indications for inhaled corticosteroids in chronic obstructive pulmonary disease (COPD), …

… delivery of steroids is associated with dry eyes and cataracts. Smoking, aging, and long-term
inhaled steroid use have all been linked to an increased risk of cataracts. Longitudinal and …

… nasal steroids are usually administered in much smaller doses than inhaled steroids, a …
not exceed 400 ug/day, whereas inhaled steroids are recommended in doses up to 1,500 to …

… risks associated with ICS tend to be minimal at short-term low-dose treatment, whereas
high-dose ICS treatment requires more attention, with possible susceptibility to both cataract …

… patients who cannot coordinate actuation and inhalation, they can alter the … risk for certain
adverse effects, such as elderly patients with an increased risk for osteoporosis and cataracts, …